Delving into the Latest Updates on Measles, mumps, rubella vaccine(BioNet-Asia Co. Ltd.) with Synapse

Overview

Basic Info

Drug Type

Combination vaccine, Prophylactic vaccine

Synonyms-

Target-

Mechanism

Immunostimulants

Therapeutic Areas

Infectious DiseasesMouth and Tooth DiseasesOther Diseases

Active Indication

MeaslesMumpsRubella

Inactive Indication-

Originator Organization

BioNet-Asia Co. Ltd.

Active Organization

BioNet-Asia Co. Ltd.

Inactive Organization-

Drug Highest PhaseApproved

First Approval Date

TH (01 Jan 2014),

MeaslesMumpsRubella

Regulation-

Login to view timeline

BACKGROUNDRoutine vaccination procedures, while crucial for public health, can induce pain, fear, and anxiety in children. Distraction techniques such as virtual reality and kaleidoscope have been proposed to alleviate these negative experiences during vaccinations.OBJECTIVEThis study aimed to compare the effectiveness of virtual reality and kaleidoscope as distraction methods in reducing pain, fear, and anxiety during routine vaccination in children aged 48 months.DESIGNThis randomized controlled trial allocated children aged 48 months receiving the measles-mumps-rubella vaccine into three groups: virtual reality (n = 42), kaleidoscope (n = 42), and control (n = 42).SETTING(S)The study was conducted in a pediatric clinic.PARTICIPANTSThe study included a total of 126 children aged 48 months.METHODSPain and fear levels were assessed by both researchers and children before and after the vaccination procedure, while anxiety was evaluated by children after vaccination. Pain was measured using the Wong Baker Faces Pain Rating Scale, fear with the Children's Fear Scale, and anxiety with the Child Anxiety Scale-State Version.RESULTSPost-vaccination pain, fear, and anxiety scores were significantly lower in the kaleidoscope group compared to both the virtual reality and control groups (p < .05).CONCLUSIONSUsing kaleidoscope during vaccination in 48-month-old children effectively reduced pain, fear, and anxiety. Integrating kaleidoscope as a distraction method during routine vaccination procedures may enhance the vaccination experience and potentially improve adherence to vaccination schedules.REGISTRATIONClinical trials number is NCT0611XXXX.

01 Aug 2024·Journal of Community Health

An Experimental Study on how Messaging from CDC Affects Attitudes toward Mandatory MMR Vaccination for Schoolchildren

Article

Author: Viskupič, Filip ; Wiltse, David L

AbstractBackgroundDuring the COVID-19 pandemic, public health institutions, particularly the Centers for Disease Control and Prevention (CDC), were frequently attacked by politicians. Popular trust in these institutions declined, particularly among self-identified Republicans. Therefore, the effectiveness of public health institutions as vaccination messengers might have been weakened in the post-COVID-19 period. We conducted a survey experiment examining the effectiveness of messaging from the CDC in shaping people’s attitudes toward mandatory MMR (measles-mumps-rubella) vaccination for schoolchildren.MethodsThe experiment was embedded in a survey fielded in South Dakota, a “red state” with a population predisposed to distrust the CDC. Using registration-sampling, we received 747 responses. We used difference-in-means tests and multivariate regression to analyze the data.ResultsWe found that participants who received a message from the CDC were more likely to support MMR vaccine mandate for schoolchildren than participants who received the same prompt from a state agency. Further analyses showed that messaging from the CDC was particularly effective among Republicans.DiscussionOverall, our study showed that although the CDC was caught up in the political skirmishes during the COVID-19 pandemic, it remains an authoritative source of public health information.ConclusionsPublic health officials at the local and state levels should not shy away from referring to the CDC in their vaccination messaging.

100 Deals associated with Measles, mumps, rubella vaccine(BioNet-Asia Co. Ltd.)

Login to view more data